Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Genetic variants other than in α-1 antitrypsin increase the risk of COPD.
|
24621683 |
2014 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Individuals with severe deficiency in serum alpha(1)-antitrypsin (AAT) concentrations are at high risk for developing chronic obstructive pulmonary disease (COPD), whereas those carrying the PI*MZ genotype are at slightly increased risk.
|
18515255 |
2008 |
Chronic Obstructive Airway Disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
All of the investigated patients with severe COPD were MM type homozygotes with normal plasma level of AAT.
|
22075288 |
2011 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Until these studies are reported, the data to date suggest that products encoded by the alpha-1 antitrypsin, some matrix metalloproteinases, and a number of antioxidant genes are associated with accelerated FEV1 decline in COPD.
|
18044683 |
2007 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The determination of this genetic deficiency prevalence in Madeira Island (Portugal) population is important to clarify susceptibility and define the relevance of performing genetic tests for AAT on individuals at risk for COPD.
|
19450958 |
2009 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease.
|
9350828 |
1997 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The objective of the present screening was to estimate the AAT gene frequency and prevalence and to identify AAT deficiency cases in a large cohort of Lithuanian patients with COPD.
|
18722101 |
2008 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In combination with smoking or other long-term noxious exposures such as occupational dust and fumes, genetic A1AT deficiency can cause chronic obstructive pulmonary disease, a condition with elevated cardiovascular risk.
|
29432934 |
2018 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
While the most common is AAT deficiency, a genetic disorder associated with chronic obstructive pulmonary disease, additional disorders associated with AAT abnormalities are increasingly recognised.
|
29592975 |
2018 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
SERPINA1 Hepatocyte-Specific Promoter Polymorphism Associate with Chronic Obstructive Pulmonary Disease in a Study of Kashmiri Ancestry Individuals.
|
29804144 |
2018 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Our results indicate that telomere length is better preserved in α1-antitrypsin deficient COPD patients than in non-deficient patients.
|
24763308 |
2014 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Ten years ago a search was initiated for DNA variation in the alpha-1-antitrypsin gene (alpha 1-AT) to determine whether there were mutations more commonly associated with patients who had chronic obstructive airways disease (COAD) than with healthy individuals.
|
7952657 |
1994 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The risk of COPD was marginally elevated for the genetic markers, MS and MZ, in the alpha(1)-antitrypsin gene [summary odds ratio: MS, 1.2 (1.0-1.4) and MZ, 2.3 (1.6-3.4)], whereas the SZ marker was an important risk factor of COPD [summary odds ratio: 3.3 (1.2-8.6)].
|
20298391 |
2009 |
Chronic Obstructive Airway Disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
COPD subjects with higher serum alpha-1 antitrypsin levels were associated with a worse systemic inflammation status and higher 10-year mortality.
|
31849461 |
2019 |
Chronic Obstructive Airway Disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Plasma alpha(1)-antitrypsin levels, annual decrease in FEV(1), airway obstruction, and hospitalization and mortality from chronic obstructive pulmonary disease (COPD).
|
11848724 |
2002 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Treatment of A1ATD-associated lung disease includes standard therapies that are also used for the treatment of COPD, in addition to the use of augmentation therapy (that is, infusions of human plasma-derived, purified α1-antitrypsin).
|
27465791 |
2016 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The presence of the alpha(1)-antitrypsin MZ genotype may in certain circumstances produce marked aggravation of airway obstruction in individuals prone to develop COPD.
|
11148177 |
2001 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In this paper we report DNA sequence heterogeneity of the AAT gene region among 137 patients with COPD and 130 healthy control subjects.
|
1969347 |
1990 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Alpha 1-antitrypsin Pi-types in 965 COPD patients.
|
3485034 |
1986 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Patients with alpha 1-antitrypsin (AAT) deficiency, like those with asthma and chronic obstructive pulmonary disease, usually present with dyspnea, wheeze, and cough.
|
9126209 |
1997 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
The SERPINA1 gene is a well-recognized genetic risk factor of COPD and it produces 11 transcript variants, which is exceptional for a human gene.
|
26480348 |
2015 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We aimed to explore the associations of rs9944155AG, rs1051052AG, and rs1243166AG polymorphisms in the Alpha-1-AT gene with the risk of COPD in Uygur population in the Kashgar region.
|
29521291 |
2018 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Severe alpha(1)-antitrypsin (AAT) deficiency is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD), especially in individuals who smoke.
|
17690329 |
2008 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
To further study the role of A1AT deficiency in the pathogenesis of COPD/emphysema, the authors attempted to generate null-mutant mice for Serpina1a, 1 of 2 A1AT orthologs in mice.
|
21574874 |
2011 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
|
24969923 |
2014 |